rivastigmine has been researched along with Vomiting in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, D; Feng, T; Ji, Y; Jia, J; Kuang, W; Li, Y; Liang, Z; Ning, Y; Peng, D; Wei, W; Xiao, S; Ye, Q | 1 |
| Deardorff, WJ; Grossberg, GT; Nieto, RA | 1 |
| Bhatnagar, V; Brannan, S; Koumaras, B; Meng, X; Olin, JT; Reyes, P | 1 |
| Darreh-Shori, T; Jelic, V | 1 |
| Pregelj, P | 1 |
| Aarsland, D; Albanese, A; Byrne, EJ; De Deyn, PP; Deuschl, G; Durif, F; Emre, M; Kulisevsky, J; Lane, R; Lees, A; Poewe, W; Quarg, P; Robillard, A; Rosa, MM; Tekin, S; van Laar, T; Wolters, E | 1 |
| Harada, CN; Sachs, GA; Shega, JW | 1 |
| Morgan, J; Sethi, KD | 1 |
| Arciniegas, D; Chen, M; Gunay, I; Harvey, PD; Katz, DI; Koumaras, B; Mirski, D; Potkin, SG; Reyes, P; Silver, JM; Warden, D | 1 |
| Burns, A; Charles, HC; Cummings, J; del Ser, T; Farlow, M; Feldman, HH; Ferris, S; Fox, NC; He, Y; Herrmann, N; Inzitari, D; Lane, R; Mancione, L; Orgogozo, JM; Potkin, S; Sauer, H; Scarpini, E; Scheltens, P; Sfikas, N; Tekin, S; Winblad, B | 1 |
| Wesnes, K | 1 |
| Landmark, K; Reikvam, A | 1 |
| Allison, M; Appel-Dingemanse, S; Ho, YY; Huang, HL; Kiese, B; Lefèvre, G; Pommier, F; Sedek, G | 1 |
2 review(s) available for rivastigmine and Vomiting
| Article | Year |
|---|---|
Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
Topics: Administration, Cutaneous; Administration, Oral; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dermatitis, Irritant; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome; Vomiting | 2010 |
Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2007 |
6 trial(s) available for rivastigmine and Vomiting
| Article | Year |
|---|---|
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Nausea; Rivastigmine; Severity of Illness Index; Treatment Outcome; Vomiting | 2019 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2004 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Aged; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Middle Aged; Nausea; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Tremor; Vomiting | 2005 |
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Topics: Adolescent; Adult; Antiemetics; Benzamides; Brain Injuries; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome; Vomiting | 2006 |
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2007 |
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Area Under Curve; Benzylamines; Biological Availability; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Cross-Over Studies; Dizziness; Female; Half-Life; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Phenethylamines; Phenols; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders; Solutions; Tandem Mass Spectrometry; Vomiting | 2008 |
5 other study(ies) available for rivastigmine and Vomiting
| Article | Year |
|---|---|
Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Humans; Nausea; Rivastigmine; Transdermal Patch; Vomiting | 2016 |
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Topics: Activities of Daily Living; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Antiparkinson Agents; Blood Pressure; Capsules; Cholinesterase Inhibitors; Cognition; Dizziness; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; Humans; Incidence; Male; Memantine; Middle Aged; Nausea; Phenylcarbamates; Pilot Projects; Prospective Studies; Rivastigmine; Vomiting | 2010 |
Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dermatitis, Contact; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neuropsychological Tests; Patient Compliance; Phenylcarbamates; Prospective Studies; Rivastigmine; Transdermal Patch; Treatment Outcome; Vomiting | 2012 |
Rivastigmine for dementia associated with Parkinson's disease.
Topics: Bias; Cholinesterase Inhibitors; Data Interpretation, Statistical; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Tremor; Vomiting | 2005 |
[Rivastigmine against dementia in Parkinson disease?].
Topics: Cholinesterase Inhibitors; Dementia; Humans; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine; Vomiting | 2007 |